Skip to content

Managing Your Glaucoma


Some common ways to treat glaucoma include eye drop medications, conventional surgery, and a state-of-the-art Micro-Invasive Glaucoma Surgery known as MIGS.

Close up of an eye with a drop of fluid falling into it from a dropper in the foreground.


The most common treatment for high intraocular pressure (IOP) and glaucoma is prescription eye drops. However, glaucoma medications are bothersome to many and are associated with side effects such as:

  • Eye redness
  • Changing color of the iris
  • Droopy eyelids
  • Darkening skin around the eye

Glaucoma medications can also interfere with your routine for the rest of your life, requiring you to make time to take them daily, ensure they are applied correctly, and continue paying for refills.

Research has shown that more than 90% of patients are non-adherent with their prescription eye drops for glaucoma, and nearly 50% stop taking their medications before 6 months.1

Even when taking glaucoma medications, you may still be at risk of disease progression.2

Micro-Invasive Glaucoma Surgery (MIGS)

Now, more micro-invasive surgical options are available for patients who are interested in effective glaucoma management without having to rely solely on the continuous use of prescription medications.

MIGS is a proven option to reduce eye pressure that can provide 24/7 control of your glaucoma by using microdevices that can’t be seen or felt. Also, unlike more invasive glaucoma surgeries, MIGS is a safer, simpler option with a faster recovery time.

Smiling man with apron holding up a barbeque lid in right hand and tongs picking up the next selection for the grill in the left. A nice sunny day, some guests sitting at a picnic table blurred out in the background.


Learn More About iStent infinite


  1. Nordstrom BL, Friedman DS, Mozaffari E, Quigley HA, Walker AM. Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol. 2005;140(4):598-606.
  2. Malihi M, Moura Filho ER, Hodge DO, Sit AJ. Long term trends in glaucoma-related blindness in Olmsted County, Minnesota. Ophthalmology. 2014;121(1):134–141.


iStent infinite® should not be used in patients with the following types of glaucoma; angle-closure, traumatic, uveitic, neovascular or glaucoma related to tumors; thyroid eye disease, Sturge-Weber syndrome, or any conditions that may cause elevated pressure in the eye. Potential Benefit of iStent infinite is the lowering of eye pressure, which may assist in the management of glaucoma. MRI environment is safe for use with iStent infinite under certain MRI conditions. Prior to having an MRI, tell your doctor you have an iStent infinite stent in your eye, and show the doctor your implant card. Potential Risks of iStent infinite may include reactions to medicines, bleeding, infection, inflammation, vision changes, increased eye pressure, and swelling of the cornea. This is not a complete list of risks. Talk to your doctor for medical advice about risks.

You are encouraged to report negative side effects to FDA at 1-800-FDA-1088.


iStent infinite is an implantable device intended to reduce the intraocular pressure (IOP) of the eye. It is indicated for use in adults with primary open-angle glaucoma in whom previous medical and surgical treatment has failed.